456 related articles for article (PubMed ID: 21079644)
1. Pharmacologic therapy for osteoarthritis--the era of disease modification.
Hunter DJ
Nat Rev Rheumatol; 2011 Jan; 7(1):13-22. PubMed ID: 21079644
[TBL] [Abstract][Full Text] [Related]
2. The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date.
Oo WM; Little C; Duong V; Hunter DJ
Drug Des Devel Ther; 2021; 15():2921-2945. PubMed ID: 34262259
[TBL] [Abstract][Full Text] [Related]
3. Current Models for Development of Disease-Modifying Osteoarthritis Drugs.
Makarczyk MJ; Gao Q; He Y; Li Z; Gold MS; Hochberg MC; Bunnell BA; Tuan RS; Goodman SB; Lin H
Tissue Eng Part C Methods; 2021 Feb; 27(2):124-138. PubMed ID: 33403944
[TBL] [Abstract][Full Text] [Related]
4. DMOAD developments: present and future.
Pelletier JP; Martel-Pelletier J
Bull NYU Hosp Jt Dis; 2007; 65(3):242-8. PubMed ID: 17922676
[TBL] [Abstract][Full Text] [Related]
5. OA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed?
Hellio Le Graverand-Gastineau MP
Osteoarthritis Cartilage; 2009 Nov; 17(11):1393-401. PubMed ID: 19426849
[TBL] [Abstract][Full Text] [Related]
6. Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics.
Oo WM; Yu SP; Daniel MS; Hunter DJ
Expert Opin Emerg Drugs; 2018 Dec; 23(4):331-347. PubMed ID: 30415584
[TBL] [Abstract][Full Text] [Related]
7. Current status and future prospects for disease modification in osteoarthritis.
Huang Z; Ding C; Li T; Yu SP
Rheumatology (Oxford); 2018 May; 57(suppl_4):iv108-iv123. PubMed ID: 29272498
[TBL] [Abstract][Full Text] [Related]
8. Prospects of Disease-Modifying Osteoarthritis Drugs.
Oo WM
Rheum Dis Clin North Am; 2024 Aug; 50(3):483-518. PubMed ID: 38942581
[TBL] [Abstract][Full Text] [Related]
9. The disease modifying osteoarthritis drug (DMOAD): Is it in the horizon?
Qvist P; Bay-Jensen AC; Christiansen C; Dam EB; Pastoureau P; Karsdal MA
Pharmacol Res; 2008 Jul; 58(1):1-7. PubMed ID: 18590824
[TBL] [Abstract][Full Text] [Related]
10. Future therapeutics for osteoarthritis.
Martel-Pelletier J; Wildi LM; Pelletier JP
Bone; 2012 Aug; 51(2):297-311. PubMed ID: 22037003
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial.
Detert J; Klaus P; Listing J; Höhne-Zimmer V; Braun T; Wassenberg S; Rau R; Buttgereit F; Burmester GR
Trials; 2014 Oct; 15():412. PubMed ID: 25348033
[TBL] [Abstract][Full Text] [Related]
12. Plain radiography or magnetic resonance imaging (MRI): Which is better in assessing outcome in clinical trials of disease-modifying osteoarthritis drugs? Summary of a debate held at the World Congress of Osteoarthritis 2014.
Eckstein F; Le Graverand MP
Semin Arthritis Rheum; 2015 Dec; 45(3):251-6. PubMed ID: 26142321
[TBL] [Abstract][Full Text] [Related]
13. Biomaterial strategies for improved intra-articular drug delivery.
Mancipe Castro LM; García AJ; Guldberg RE
J Biomed Mater Res A; 2021 Apr; 109(4):426-436. PubMed ID: 32780515
[TBL] [Abstract][Full Text] [Related]
14. Emerging pathways and promising agents with possible disease modifying effect in osteoarthritis treatment.
Jotanovic Z; Mihelic R; Sestan B; Dembic Z
Curr Drug Targets; 2014 Jun; 15(6):635-61. PubMed ID: 24597569
[TBL] [Abstract][Full Text] [Related]
15. Osteoarthritis.
Hunter DJ
Best Pract Res Clin Rheumatol; 2011 Dec; 25(6):801-14. PubMed ID: 22265262
[TBL] [Abstract][Full Text] [Related]
16. Rationale for the use of structure-modifying drugs and agents in the treatment of osteoarthritis.
Pelletier JP
Osteoarthritis Cartilage; 2004; 12 Suppl A():S63-8. PubMed ID: 14698646
[TBL] [Abstract][Full Text] [Related]
17. Osteoarthritis phenotypes and novel therapeutic targets.
Van Spil WE; Kubassova O; Boesen M; Bay-Jensen AC; Mobasheri A
Biochem Pharmacol; 2019 Jul; 165():41-48. PubMed ID: 30831073
[TBL] [Abstract][Full Text] [Related]
18. Emerging pharmaceutical therapies for osteoarthritis.
Latourte A; Kloppenburg M; Richette P
Nat Rev Rheumatol; 2020 Dec; 16(12):673-688. PubMed ID: 33122845
[TBL] [Abstract][Full Text] [Related]
19. Disease modification in osteoarthritis: are we there yet?
Oo WM; Hunter DJ
Clin Exp Rheumatol; 2019; 37 Suppl 120(5):135-140. PubMed ID: 31621568
[TBL] [Abstract][Full Text] [Related]
20. Investigational drugs for the treatment of osteoarthritis, an update on recent developments.
Zhu Z; Li J; Ruan G; Wang G; Huang C; Ding C
Expert Opin Investig Drugs; 2018 Nov; 27(11):881-900. PubMed ID: 30345826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
